Both PTP1B and AR are considered as emerging targets involved in the onset and progression of chronic multifactorial diseases, such as type 2 Diabetes Mellitus (T2DM), obesity, cancer and, more generally, inflammatory-based diseases [13,14]. The gene discussed is PTPN1; the disease is type 2 diabetes mellitus.